Host responses to infection with human papillomavirus

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• Human papillomavirus (HPV) infections are widespread, with most individuals clearing the virus without symptoms.
• However, some develop persistent infections and lesions, particularly those with immunodeficiencies like HIV.
• CD4 T cells are critical for controlling established HPV infections and preventing disease progression.

Purpose of the Study:

• To explore the role of the immune system in controlling HPV infections.
• To understand how immune defects facilitate viral persistence and cancer development.
• To highlight the mechanism of prophylactic HPV L1 virus-like particle (VLP) vaccines.

Main Methods:

• The study reviews existing literature on HPV immunology and vaccine mechanisms.
• It discusses the importance of cell-mediated immunity and T cell responses in HPV clearance.
• It analyzes the impact of immunodeficiency on HPV control and disease progression.

Main Results:

• Defective immune responses, including impaired innate immunity and adaptive immune priming, lead to HPV persistence.
• Immunosuppression creates an HPV antigen-tolerant environment, compromising host defenses.
• Neoplastic cells evade immune detection and killing, facilitating cancer development.

Conclusions:

• Effective immune responses are essential for clearing HPV infections and preventing associated cancers.
• Prophylactic HPV L1 VLP vaccines administered intramuscularly induce robust T cell-dependent B cell responses.
• These vaccines generate high levels of neutralizing antibodies and immune memory, circumventing viral evasion strategies.